Dennis M. Brown
Dennis M. Brown founded Matrix Pharmaceutical, Inc., Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. and ChemGenex Therapeutics, Inc. Dr. Brown occupies the position of Chairman at Cell Source, Inc., Chairman of Mountain View Pharmaceuticals, Inc., President for Valent Technologies LLC and Chief Scientific Officer of Kintara Therapeutics, Inc., Director & Chief Scientific Officer at Del Mar Pharmaceuticals (BC) Ltd. (a subsidiary of Kintara Therapeutics, Inc.). Dr. Brown is also on the board of Rakovina Therapeutics, Inc., Azora Therapeutics, Inc. and Medasystems, Inc. and Member-Research Roundtable at National Brain Tumor Society, Inc.
In his past career he occupied the position of Vice President-Discovery Research at Matrix Pharmaceutical, Inc., Advisor at EGB Ventures LLC, President & Executive Director at ChemGenex Pharmaceuticals Pty Ltd., Assistant Professor at Harvard Medical School and Associate at Stanford University School of Medicine.
Dennis M. Brown received an undergraduate degree, a graduate degree and a doctorate from New York University.
Transactions
| 06/30/2020 | 17 | 0 | |
| 03/31/2020 | 17 | 0 | |
| 12/31/2019 | 17 | 0 | |
| 12/27/2019 | 7,500 | Gift at $0 per share. | 0 |
| 09/30/2019 | 17 | 0 | |
| 06/28/2019 | 17 | 0 | |
| 03/29/2019 | 169 | 82 | |
| 12/31/2018 | 169 | 57 | |
| 12/21/2018 | 85,000 | Gift at $0 per share. | 0 |
| 09/28/2018 | 169 | 540 | |
| 06/29/2018 | 169 | 540 | |
| 03/30/2018 | 169 | 540 | |
| 12/31/2017 | 169 | 540 | |
| 12/13/2017 | 129,600 | Gift at $0 per share. | 0 |
| 09/29/2017 | 169 | 540 | |
| 06/30/2017 | 169 | 540 |
